Project CBD
NOVEMBER 7, 2018
How often have we heard, “More research is needed,” from those who would prefer to see no change in policies that should be informed by science? From climate denial to cannabis prohibition, the demand for absolute scientific certainty is a call for inaction. It begs the question: When is there “enough” research? How about not enough to eliminate all uncertainties, but enough to recommend medical treatment or change policy?
Americans for Safe Access
NOVEMBER 9, 2018
This week has been big for cannabis in electoral politics. Thanks to Tuesday’s election, thirty-three states now have a comprehensive medical cannabis program. Ballot victories in Missouri and Utah transitioned these states’ low-THC CBD programs to significantly broader access. Voters in eleven Wisconsin counties and one city approved non-binding referendums supporting medical cannabis legislation.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Greencamp
NOVEMBER 9, 2018
This might sound weird and ridiculous but contrary to popular opinion, cannabis can help asthmatics in many ways. I couldn’t believe it myself when I first started research for this article, but, as it seems, compounds found in cannabis can relieve certain acute and life-threatening symptoms of asthma. When you think about cannabis, I bet the first thing that pops into your mind is smoking a joint.
Medicinal Marijuana Association
NOVEMBER 7, 2018
In the last few years, there has been growing interest in cannabis and what it can do in the medical field. More research than ever before is being conducted, and more medical professionals are beginning to embrace it as a potential treatment for their patients.
Speaker: Jonathan Bench, International Cannabis and Securities Business Attorney at Harris Bricken
The U.S. cannabis industry is still in its infancy, even though states began engaging with legalization in one form or another in the late 1990s. Today, many opportunities exist for individuals and businesses that want to engage in the industry. Some want to directly own licensed businesses, while others prefer to keep the industry at an arm’s length and merely profit from it.
Project CBD
NOVEMBER 7, 2018
How often have we heard, “More research is needed,” from those who would prefer to see no change in policies that should be informed by science? From climate denial to cannabis prohibition, the demand for absolute scientific certainty is a call for inaction. It begs the question: When is there “enough” research? How about not enough to eliminate all uncertainties, but enough to recommend medical treatment or change policy?
Medical Cannabis Brief brings together the best content for patients and advocates from the widest variety of industry thought leaders.
SMPL
NOVEMBER 8, 2018
Southern University has given Advanced Biomedics until next Thursday to pay $2.15 million to the university and make progress on its medical marijuana growing operations, warning the company in a letter that otherwise the university would be “forced” to pick someone else to run its program. Read more.
Weedistry
NOVEMBER 5, 2018
After a judge ruled in Florigrown’s favor, the state appealed. What’s next? A broad legal battle has marinated in a Florida courthouse for nearly a year, and now the state’s House of Representatives is inserting itself into the proceedings. The House’s recent filing seeks to defend lawmakers’ interpretation of the constitutional amendment that paved the way for Florida’s nascent medical marijuana market.
Cannabis Cheri
NOVEMBER 6, 2018
Guest post by Lanny Swerdlow, RN, LNC. Due to its psychoactive properties, THC gets all the hype, but it is only one of about 60 cannabinoids found in marijuana. These complex organic molecules found in cannabis have a profound effect on our bodies if for no other reason than we naturally produce cannabinoids, called endocannabinoids, for a virtual cornucopia of physiological processes.
SMPL
NOVEMBER 7, 2018
See the results for each state below: Michigan Passes. North Dakota fails. Missouri Passes. Utah Passes.
Weedistry
NOVEMBER 4, 2018
Families of children with epilepsy say they are devastated after being denied prescriptions for medicinal cannabis. A law change on 1 November was designed to allow a small number of patients to be prescribed cannabis-based products by specialist doctors in the UK. The United Patients Alliance (UPA) said the new prescribing rules were unclear. NHS England said patients with an unmet need, where there was evidence they would benefit, could be given a prescription.
Expert insights. Personalized for you.
272 
Let's personalize your content